BMAL1 and cancer: Together, FLIM data and metabolomics analyses illustrate that transformed Apc+/−;Bmal1−/− organoids exhibit heightened glycolytic metabolism and activation of branch point pathways that are required to sustain enhanced growth of cancer cells.